(2일차) 대한진단검사의학회 국제학술대회(LMCE 2026)

세부 일정 (125강)

• 09:00~09:30 Regulatory and Management Framework for Clinical Performance Testing Institution in Korea Walker 1 (1F) 김국한(식품의약품안전평가원 혁신진단기기정책과)
• 09:30~10:00 Comparative Analysis of Korean and International Regulatory Frameworks for Clinical Performance Studies of In Vitro Diagnostic Medical Devices Walker 1 (1F) 권석륜(서울의대)
• 10:00~10:30 Enhancing the Reliability of Clinical Performance Studies for In Vitro Diagnostic Medical Devices: Policy Recommendations Walker 1 (1F) 한민제(한림의대)
• 10:30~10:40 휴식 Walker 1 (1F) ()
• 10:40~11:30 Newborn Screening: Addressing the Current Status of Newborn Screening in the United States - What is the Clinical Laboratory’s Role? 공통 Stanley F. Lo(Association for Diagnostics & Laboratory Medicine)
• 11:30~12:30 식사 Walker 1 (1F) ()
• 12:30~13:20 Tumor Markers: Classic and New Markers Used in Personalized Medicine 공통 Tomas Zima(European Federation of Clinical Chemistry and Laboratory Medicine (EFLM))
• 13:20~13:50 What Humans (But Not AI) Can Do: Time & Space Integrative Pathobiological Science Walker 1 (1F) Shuji Ogino(Harvard Medical School)
• 13:50~14:20 Need-to-know AI Checklists and Guidelines in Clinical Laboratories Walker 1 (1F) 박경운(서울의대)
• 14:20~14:50 Privacy Protection in the Era of Generative Artificial Intelligence Walker 1 (1F) 윤형진(서울의대)
• 14:50~15:00 휴식 Walker 1 (1F) ()
• 15:00~15:30 Advances in Blood-Based Biomarkers for Alzheimer’s Disease: From Research to Clinical Application Walker 1 (1F) Danni Li(Laboratory Medicine and Pathology, the University of Minnesota)
• 15:30~16:00 Biomarkers and Precision Medicine Approaches in Alzheimer’s Disease and Neurological Disorders Walker 1 (1F) 임현국(가톨릭의대 정신건강의학과)
• 16:00~16:30 Commercialization and Analytical Performance of Blood-Based Biomarkers for Alzheimer’s Disease Walker 1 (1F) 이상국(연세의대)
• 16:30~16:40 휴식 Walker 1 (1F) ()
• 16:40~17:10 Clinical Application of AI for Morphologic Analysis of Blood Cells (tentative) Walker 1 (1F) Giuseppe d(Catholic University of Rome)
• 17:10~17:40 LLM-based Clinical Decision Support for Bone Marrow Interpretation in Hematologic Malignancies Walker 1 (1F) 육희정(강원의대)
• 17:40~18:10 Use of Artificial Intelligence in Predicting the Prognosis of Patients with Hematologic Malignancies Walker 1 (1F) 송가영(전남의대 혈액종양내과)
• 09:00~09:25 Smart Automation Platform to Optimize Lab Efficiency and Flexibility Walker 2 (1F) 이성혁(㈜한랩)
• 09:25~09:50 Clinical Performance and Usability Evaluation of the ConfiSign HIV Self-Test Kit Across Diverse Healthcare Settings Development and Global Clinical Evaluation of the ConfiSign HIV Self-Test Kit for Expanding Access to HIV Screening Walker 2 (1F) 문정대(㈜젠바디)
• 09:50~10:10 A Novel Approach to MSI Detection: Liquid Biopsy-Based Analysis Without Matched Normal Samples Using the dTOP™ MSI Detection Kit Walker 2 (1F) 김현선(㈜시선바이오머티리얼스)
• 10:10~10:30 Two Next-Generation Molecular Diagnostic Platforms for Infectious Diseases: Fully Automated High-Throughput System and Point-of-Care System Walker 2 (1F) 이찬효(바이오니아)
• 10:30~10:40 휴식 Walker 2 (1F) ()
• 10:40~11:30 Newborn Screening: Addressing the Current Status of Newborn Screening in the United States - What is the Clinical Laboratory’s Role? 공통 Stanley F. Lo(Association for Diagnostics & Laboratory Medicine)
• 11:30~12:30 식사 Walker 2 (1F) ()
• 12:30~13:20 Tumor Markers: Classic and New Markers Used in Personalized Medicine 공통 Tomas Zima(European Federation of Clinical Chemistry and Laboratory Medicine (EFLM))
• 13:20~13:35 Building Smart Laboratory: Progress and Challenge— A Thailand Perspective Walker 2 (1F) Busadee Pratumivinit(Mahidol University)
• 13:35~13:50 From Bench to Bedside: Enhancing Automated Image Analysis with Explainable Grad-CAM++ Visualization Walker 2 (1F) Nguyen Truong Cong Minh(University Medical Center Ho Chi Minh City)
• 13:50~14:05 Building Smart Laboratories: Progress, Challenges and Future Directions in Myanmar Walker 2 (1F) Aye Aye Khin(Department of Medical Research, Victoria Hospital)
• 14:05~14:20 Building Smart Laboratories: Progress, Challenges and Future Directions in Mongolia Walker 2 (1F) Munkhtuvshin Oyundelger(Mongolian Association of Laboratory Medicine and Etugen University)
• 14:20~14:35 From Development to Deployment: Machine Learning Applications in Laboratory Medicine in Japan-Insights from Liver Disease Models Walker 2 (1F) Masaya Sato(Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo)
• 14:35~14:50 Building Smart Laboratories: Progress, Challenges and Future Directions in Taiwan Walker 2 (1F) Pei-Chin Lin(Taiwan Society of Clinical Pathology and Laboratory Medicine)
• 14:50~15:00 휴식 Walker 2 (1F) ()
• 15:00~15:20 Building Smart Laboratories: Progress, Challenges and Future Directions in Indonesia Walker 2 (1F) Teguh Triyono(Indonesian Association of Pathologists and Laboratory Medicine)
• 15:20~15:40 Building Smart Laboratories: Progress, Challenges and Future Directions in India Walker 2 (1F) Deepak Kumar Mishra(Indian College of Pathology)
• 15:40~16:00 Building Smart Laboratories: Progress, Challenges and Future Directions in Korea Walker 2 (1F) 전병열(순천향의대)
• 16:00~16:15 Development of Laboratory Medicine: China Perspective Walker 2 (1F) Chuanxin Wang(Chinese Society of Laboratory Medicine)
• 16:15~16:30 Building Smart Laboratories: Progress, Challenges and Future Directions in Senegal Walker 2 (1F) Rokhaya Diagne(Laboratoire National de Sante Publique (LNSP))
• 16:30~16:40 휴식 Walker 2 (1F) ()
• 16:40~17:10 Outcome-Driven Quality in Modern Laboratory Stewardship Walker 2 (1F) Andrew Don-Wauchope(Pathology and Molecular Medicine, McMaster University, Canada; Department of Chemical Pathology, Laverty Pathology Laboratory, Australia)
• 17:10~17:40 Key Considerations for Establishing Effective Laboratory Stewardship Walker 2 (1F) 이재현(전북의대)
• 17:40~18:10 The Future of Laboratory Stewardship: Supported and Accelerated by AI Walker 2 (1F) 박근열(한양의대)
• 09:00~09:30 Methodological Quality Assessment in Cochrane Diagnostic Test Accuracy Reviews Art Hall (4F) Bada Yang(Department of Epidemiology & Data Science, Amsterdam University Medical Center)
• 09:30~10:00 From QUADAS-2 to QUADAS-AI: Risk-of-Bias Assessment for AI-Based Diagnostic Tests Art Hall (4F) 신성환(울산의대)
• 10:00~10:30 Systematic Review of Diagnostic Test Accuracy in Korea Art Hall (4F) 최미영(한국보건의료연구원)
• 10:30~10:40 휴식 Art Hall (4F) ()
• 10:40~11:30 Newborn Screening: Addressing the Current Status of Newborn Screening in the United States - What is the Clinical Laboratory’s Role? 공통 Stanley F. Lo(Association for Diagnostics & Laboratory Medicine)
• 11:30~12:30 식사 Art Hall (4F) ()
• 12:30~13:20 Tumor Markers: Classic and New Markers Used in Personalized Medicine 공통 Tomas Zima(European Federation of Clinical Chemistry and Laboratory Medicine (EFLM))
• 13:20~13:50 Quality Control and Standardization of Microbiome Analysis for Clinical Testing Art Hall (4F) 김도균(연세의대)
• 13:50~14:20 Microbiome as a Clinical Biomarker in Cervical Insufficiency: Opportunities and Limitations Art Hall (4F) 정세리(한림의대)
• 14:20~14:50 Translating Microbiome Research into Clinical Therapeutics: Lessons from LBP Development Art Hall (4F) 윤상선(연세의대 미생물학교실)
• 14:50~15:00 휴식 Art Hall (4F) ()
• 15:00~15:25 Assessment of Machine Learning Classifiers for Predicting Intraoperative Blood Transfusion Art Hall (4F) 박인선(서울의대 마취통증의학과)
• 15:25~15:45 Do Explanations Change Decisions?: SHAP vs Clinician-Friendly Explanations in Transfusion Decision Art Hall (4F) 유준상(삼성융합의과학원)
• 15:45~16:10 CAR-NK Cells: Initial Development and Current Advancements Art Hall (4F) Chihaya Imai(Department of Pediatrics, Faculty of Medicine, University of Toyama)
• 16:10~16:30 Targeted Gene Knockout to Enhance CAR-T and CAR-NK Cell Therapy Art Hall (4F) Tung Nguyen Thanh Uong(성균관대학교)
• 16:30~16:40 휴식 Art Hall (4F) ()
• 16:40~17:10 The Human Pangenome Project Art Hall (4F) Ting Wang(Genetics and Computer Science and Engineering, Washington University in St. Louis)
• 17:10~17:40 AI-based Tumor Fraction Estimation with LLM-powered Integrated Interpretation Art Hall (4F) 이세준(분당서울대학교병원 정밀의료센터)
• 17:40~18:10 Gene Expression-Based Machine Learning Classifiers for Acute Lymphoblastic Leukemia Subtyping Art Hall (4F) 신새암(연세의대)
• 08:00~08:10 (구연) Machine Learning-Based Detection of Potassium Ethylenediaminetetraacetic Acid Contamination Using Routine Laboratory Test Results Grand 4+5 (B1) Hee Jun Yun(Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea)
• 08:10~08:20 (구연) Optimizing Aminotransferase Assessment: Cross-Platform validation of a Pyridoxal-5 Grand 4+5 (B1) Atchara Dawangpa(Faculty of Medicine Siriraj Hospital, Mahidol University)
• 08:20~08:30 (구연) Clinical Utility of Clobazam Therapeutic Drug Monitoring: A Ten-Year Large-Scale Experience in Korean Patients with Epilepsy Grand 4+5 (B1) Jiye Lee(Samsung Medical Center, Sungkyunkwan University School of Medicine)
• 08:30~08:40 (구연) AI-based Prediction of Hypertension and Diabetic Nephropathy Risk Using TyG-Related Predictors Through Multilayer Perceptron Neural Networks: A Proof-of-Concept Study Grand 4+5 (B1) Kristin Chernelle Dela Cruz(Angeles University Foundation)
• 08:40~08:50 (구연) Distribution Patterns and Immunophenotypic Clustering of Immunoglobulin G Subclasses in Preterm Neonates Grand 4+5 (B1) John Hoon Rim(Yonsei University College of Medicine)
• 08:50~09:00 (구연) ElectroVision AI: Computer Vision for Quantitative Lipoprotein Phenotyping and Interpretation in Digital Chemical Pathology Grand 4+5 (B1) Pak Lam Chan(Queen Mary Hospital)
• 09:00~09:10 (구연) SnackPGx: An Automated Software Tool for Diplotype Determination and Report Generation in Clinical Pharmacogenetic Testing Grand 4+5 (B1) SOOHO YU(Samsung Medical Center)
• 09:10~09:20 (구연) Development and Validation of a Custom-Modified hg38 Reference Genome Sequence for Next-Generation Sequencing Grand 4+5 (B1) You-Keun Ko(Samsung Medical Center, Sungkyunkwan University School of Medicine)
• 09:20~09:30 (구연) Development and Evaluation of a Polyamine-Based Recovery and Concentration Platform for Liquid Biopsy Applications: cfDNA, miRNA, and Extracellular Vesicles Grand 4+5 (B1) Arizumi Kikuchi(Daiyukai Health System)
• 09:30~09:40 (구연) Blinded Benchmarking of Three Frontier Large Language Models for Interpreting Germline Variants of Uncertain Significance in a Clinical Diagnostic Laboratory Grand 4+5 (B1) Hyerin Kim(Pusan National University Hospital)
• 09:40~09:50 (구연) Resolving allele-specific transcripts in low-frequency CRISPR-edited cell populations through enriched long-read sequencing Grand 4+5 (B1) Jieun Kim(Soonchunhyang University Seoul Hospital)
• 09:50~10:00 휴식 Grand 4+5 (B1) ()
• 10:00~10:10 (구연) From Digitalization to Smart Laboratories: Experiences in Integrating AI, LIS, and EMR at a Hospital in Vietnam. Grand 4+5 (B1) Tran Pham Van(103 Hospital)
• 10:10~10:20 (구연) A Simplified Polydopamine Nanoparticle-Based Electrochemical Immunosensor for Point-of-Care Cotinine Detection in Urine via Direct Covalent Antibody Immobilization Grand 4+5 (B1) Ohnmar Zaw(Graduate School, Khon Kaen University)
• 10:20~10:30 (구연) ChatGPT peripheral blood smear interpretation for anemia diagnosis: A proof-of-concept analysis using the AneRBC dataset Grand 4+5 (B1) Cherry Pie Fernandez(Angeles University Foundation)
• 10:30~10:40 (구연) Beyond the Needle: Medical Laboratory Science Interns’ Experiences Learning Phlebotomy Through a Hybrid Learning Approach Grand 4+5 (B1) AILA MAE CANLAS(Angeles University Foundation)
• 10:40~10:50 (구연) Association Between Distributional Characteristics of Patient Results and Performance of Patient-Based Real-Time Quality Control Under Various Optimization Schemes Grand 4+5 (B1) Hyeongseok Lee(Ulsan University Hospital)
• 10:50~11:00 (구연) Artificial Intelligence Enables Automated Error Detection in Routine Clinical Chemistry Across Multiple Centers Grand 4+5 (B1) Yuna Choi(Seoul Asan Medical Center)
• 11:00~11:10 (구연) Enhancing Model-Informed Precision Dosing of Vancomycin through Machine Learning-Assisted Population Pharmacokinetic Model Selection Grand 4+5 (B1) Lee Hyunwoo(Samsung Medical Center)
• 11:10~11:30 휴식 Grand 4+5 (B1) ()
• 11:30~12:30 식사 Grand 4+5 (B1) ()
• 12:30~13:00 휴식 Grand 4+5 (B1) ()
• 13:00~13:10 (구연) Current Practices in Bone Marrow Examination and Reporting: A Nationwide Survey in Korea – Pre-analytical Phase Grand 4+5 (B1) Sumi Yoon(Chung-Ang University College of Medicine)
• 13:10~13:20 (구연) Current Practices in Bone Marrow Examination and Reporting: a Nationwide Survey in Korea – Analytical and Postanalytical Phases Grand 4+5 (B1) Hanah Kim(Konkuk University School of Medicine, Seoul, Korea)
• 13:20~13:30 (구연) Beyond W515: Clinically Relevant Non-W515 MPL Mutations Identified by Next-Generation Sequencing in Myeloid Neoplasms Grand 4+5 (B1) Sooyong Park(Chungnam National University Hospital)
• 13:30~13:40 (구연) Morphologic Diversity And Molecular Correlates In Nodal T-Follicular Helper Cell Lymphoma, Follicular Type Grand 4+5 (B1) YU OKIMOTO(Okayama University Graduate School of Health Sciences)
• 13:40~13:50 (구연) Next-Generation Point-of-Care Hematology: Integrating Artificial Intelligence, Digital Morphology, and Diagnostic Analytics Grand 4+5 (B1) TUSHAR SEHGAL(ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI)
• 13:50~14:00 (구연) Prognostic Value of Thromboelastography-Derived Thrombogenicity Indices and Hemostatic Biomarkers for Perioperative Cardiovascular Risk Assessment Grand 4+5 (B1) Hendrianus Hendrianus(Natuna General Hospital)
• 14:00~14:10 (구연) Reassessment of F7 Variants Using the Updated ClinGen PP4 Guidance in Korean Patients with Congenital Factor VII Deficiency Grand 4+5 (B1) Ari Ahn(Samsung Medical Center)
• 14:10~14:20 (구연) Histopathological features and underlying molecular mechanisms of iMCD-IPL revealed by scRNA‑flex analysis Grand 4+5 (B1) Tomoka Haratake(Okayama University)
• 14:20~14:30 (구연) Immunogenic donor HLA-DQ eplets associated with de novo DQ donor-specific antibodies in Korean living-donor kidney transplant recipients Grand 4+5 (B1) Inseong OH(Seoul National University College of Medicine)
• 14:30~14:40 (구연) Evaluation of TAP-1/TAP-2 Expression and Inflammatory Markers in Oral Squamous Cell Carcinoma and Premalignant Oral Lesions: Implications for Disease Monitoring and Prognostic Assessment Grand 4+5 (B1) Neeraja Suresh(All India Institute of Medical Sciences)
• 14:40~14:50 (구연) Comparison of ANA Pattern Classification Across Three Fully Automated Indirect Immunofluorescence Analyzer Systems: A Multicenter Study Grand 4+5 (B1) Hyun-Woo Choi(Chonnam National University Hospital)
• 14:50~15:00 휴식 Grand 4+5 (B1) ()
• 15:00~15:10 (구연) Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates: co-existence of blaOXA-23 and blaNDM-1 in a Vietnamese tertiary hospital Grand 4+5 (B1) Chau Minh Quynh(University Medical Center)
• 15:10~15:20 (구연) Rapid Genomic Surveillance of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) in Hospital Settings: The Transformative Role of Oxford Nanopore Technologies (ONT) Grand 4+5 (B1) DIEP DUONG THI HONG(University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam)
• 15:20~15:30 (구연) Development of recombinase polymerase amplification (RPA) combined with visual lateral flow assay (LFA) for ESBLs and colistin-resistant gene detection. Grand 4+5 (B1) Nuntaree Chaichanawongsaroj(Faculty of Allied Health Sciences, Chulalongkorn University)
• 15:30~15:40 (구연) Optimizing Candidozyma (Candida) auris surveillance: Diagnostic performance of different swab and transport media combinations for patient and environmental screening Grand 4+5 (B1) Jung-ah Kim(Soonchunhyang University Seoul Hospital)
• 15:40~15:50 (구연) Comparative Analysis of Antifungal Susceptibility and Resistance-Associated Genetic Variations among Korean Candida auris Clades Grand 4+5 (B1) Yong Jun Kwon(Chonnam National University Hospital)
• 15:50~16:00 (구연) Primer Blind Spots: Underrepresentation of ESKAPE Pathogens from Developing Regions in 16S rRNA Targeted Sequencing Grand 4+5 (B1) Khushi Chouhan(IIT Delhi)
• 16:00~16:10 (구연) Nasal Carriage of Methicillin-resistant Staphylococcus aureus and its Association with Knowledge and Attitudes on Nosocomial Infection and PPE Use Grand 4+5 (B1) Jaeden Balinas(Angeles University Foundation)
• 16:10~16:20 (구연) Prolonged SARS-CoV-2 Infection in a B-Cell-Depleted Patient: Intra-Host Evolution Leading to Remdesivir Resistance and PCR E Gene Dropout Grand 4+5 (B1) Sung Eun Hong(Samsung Medical Center)
• 16:20~16:30 (구연) Antimicrobial Resistance Across the COVID-19 Pandemic Periods, 2019–2024 Grand 4+5 (B1) Khosbayar Tulgaa(Mongolian National University of Medical Sciences)
• 16:30~16:40 (구연) Whole-Genome Sequencing Analysis of Hypervirulent ST1 and ST11 and Regionally Prevalent ST17 and ST37 Clostridioides difficile Lineages from a Korean Hospital Grand 4+5 (B1) SEONGJIN CHO(Hallym Sacred Heart Hospital)
• 16:40~16:50 휴식 Grand 4+5 (B1) ()
• 16:50~17:00 (구연) Transforming Transfusion Safety Through Failure Mode and Effects Analysis (FMEA) and BOTS Software Integration: A Proactive Risk Reduction Model in Hospital Transfusion Practice Grand 4+5 (B1) DEEPTHI KRISHNA(DR. RELA INSTITUTE & MEDICAL CENTRE)
• 17:00~17:10 (구연) Preliminary Validation of a Double-Spin Protocol for Preparing Leukocyte-Poor and Leukocyte-Rich Platelet-Rich Plasma Grand 4+5 (B1) Raphael Enrique Tiongco(Angeles University Foundation)
• 17:10~17:20 (구연) Role And Effectiveness Of Therapeutic Plasma Exchange In Medical Renal Diseases In The Era Of Evolving ASFA Recommendations:- A 7 year Experience From A Tertiary-Care Hospital In North India Grand 4+5 (B1) Dixa Kumari(All India Institute of Medical Sciences, Rishikesh, India)
• 17:20~17:30 (구연) Changes in Blood Viscosity and RBC Parameters During Storage of Red Blood Cell Units Grand 4+5 (B1) Jongho Yi(Konkuk University Medical Center)
• 17:30~17:40 (구연) Lipid Multi-Trajectories Could Predict Post-transplant Outcomes in Acute Myeloid Leukemia Grand 4+5 (B1) Hongru Chen(Peking University of People)
• 17:40~17:50 (구연) Human-in-the-Loop Image Analysis of Wright-Stained Platelet Concentrate Bag Segments in Relation to Complete Blood Count-Derived Platelet Indices Grand 4+5 (B1) Koudai I. Albaira(Biomedical Research Institute)
• 17:50~18:00 (구연) Revisiting RHD Coding Variants Through Splicing Prediction Grand 4+5 (B1) Sung Eun Hong(Samsung Medical Center)
• 09:00~09:30 The Challenging Task of Measuring and Interpreting Lp(a) Concentrations for Cardiovascular Risk Prediction Vista 1+2 (B2) Leslie J. Donato(Mayo Clinic)
• 09:30~10:00 Phase 3 Trials for Lp(a)-Lowering Drugs and Why Lipoprotein(a) Must Be Measured Inhouse in All Clinical Chemistry Laboratories Vista 1+2 (B2) Borge Nordestgaard(University of Copenhagen)
• 10:00~10:30 Roadmap to Lp(a) Test Standardization with the Next Generation IFCC-Endorsed Standard Reference Measurement System for Apolipoprotein(a) Vista 1+2 (B2) Christa Cobbaert(Leiden University Medical Center)
• 10:30~10:40 휴식 Vista 1+2 (B2) ()
• 10:40~11:30 Newborn Screening: Addressing the Current Status of Newborn Screening in the United States - What is the Clinical Laboratory’s Role? 공통 Stanley F. Lo(Association for Diagnostics & Laboratory Medicine)
• 11:30~12:30 식사 Vista 1+2 (B2) ()
• 12:30~13:20 Tumor Markers: Classic and New Markers Used in Personalized Medicine 공통 Tomas Zima(European Federation of Clinical Chemistry and Laboratory Medicine (EFLM))
• 13:20~13:50 Keeping the CAP Laboratory Accreditation Program Applicable Vista 1+2 (B2) Kathleen Beavis(University of Chicago)
• 13:50~14:20 Learnings from the Global CAP Laboratory Accreditation Program Vista 1+2 (B2) Qihui "Jim" Zhai(President, College of American Pathologists (CAP))
• 14:20~14:50 Standard Development and Revision Process of LMF Vista 1+2 (B2) 강소영(경희의대)
• 14:50~15:00 휴식 Vista 1+2 (B2) ()
• 15:00~15:40 AI Perspectives as Medical Device Vista 1+2 (B2) Sergio Bernardini(International Federation of Clinical Chemistry and Laboratory Medicine)